Trial reportPediatric obesity2026
Pilot Randomised Trial of Calibrated Formula Volumes to Optimise Growth in Infants at Risk for Overweight: The Califormula Randomised Clinical Trial.
Trial report in Pediatric obesity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05104073 (Califormula Study), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Califormula Study: Calibrated Formula Feeding to Optimize Infant Growth
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundFormula feeding and having a mother with overweight are associated with overweight during infancy.
objectivesWe sought to pilot test calibrated formula feeding guidance using age and weight specific intake recommendations to improve weight outcomes amongst at-risk infants.
methodsExclusively formula fed newborns with birthweight ≥ 50th percentile delivered to mothers with pre-pregnancy body mass index (BMI) ≥ 25 kg/m
resultsSixty infants were enrolled; 36 mothers (66.7%) had pre-pregnancy BMI ≥ 30. Seventeen (28.3%) withdrew before 6 months. At each assessment, a minority had WFL ≥ 75th percentile required to receive calibrated formula guidance. There were no group differences in CWG (intervention mean 0.27, 95% CI -0.20 to 0.75 vs. control mean -0.12, 95% CI -0.62 to 0.37; p = 0.25) or for secondary outcomes.
conclusionsCalibrated infant formula recommendations were not associated with growth outcomes.
trial registrationClinicaltrials.gov identifier: NCT05104073 (registered October 11, 2021).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.